|Day Low/High||206.47 / 211.38|
|52 Wk Low/High||130.85 / 250.46|
Expanded (I don't think I mentioned buying on Friday - was $90 last month, now $47), , and this morning.
Trading at almost a 40% discount to its book value, investors and traders have rarely seen such an opportunity to become a Partner of Goldman Sachs !
* Before you read this opening missive be sure you understand your risk appetite and profile as well as your time frame * I see a possible "generational" investment opportunity developing and I am now even more aggressively buying for the intermedia...
Be clear about your trading and investing style and don't confuse a bounce with a bottom.
I will have more on Monday but I am making my "Trade of the Week" (next week). Trading at a one third discount to its book value, investors and traders have rarely seen such an opportunity to become a Partner of Goldman Sachs!
* Ns over Ss! * The lingering impact of COVID-19 on our behavior helps to explain my large long investments in Google, Amazon and Twitter * Banks were the problem in the last recession, they will be part of the solution over the next few years I am ...
There's a pretty good chance that at some point, I will wish that I was longer.
I added to , , , , , , and this morning. A reminder that yesterday I initiated new positions in , , , , and .
When the central bank is on top of their game as they have been of late, credit must go where credit is due.
Apple and these other big names must break the December 2018 lows to reach an investable level again.
I'm not willing to stick my neck out right now and take an equity stake.
The technical signs of the financial giant warn of potential steep losses due to little in the way of chart support.
In the 2nd of a 3-part series, Jim Cramer goes through all 30 Dow stocks to evaluate what is safe to buy and what you should sell or avoid (like the plague).
Let's see, what does the guide to the entire universe have to say that could possibly help us in the face of a virulent virus? Two words.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.
This morning I moved to medium-sized , , and longs. And I moved back to large-sized on and . I have a busy research schedule today (mostly phoners) but I will outline the case for buying early tomorrow morning.
The charts of the payments giant suggest there is further risk ahead, so check your cost basis and take appropriate action.
I have moved back to large on and (I have been a scale buyer in both). And my position is now medium-sized (also scale buyer lower).
Recently, as posted in my Diary, I sold out the last of my Goldman Sachs close to $240/share. After my sale, the shares proceeded to trade to near $250/share. I just reestablished a small long at $219.75 (-$5 today) as the share price has moved back...
* At the market highs the S&P 500 Index was approximately 15%-20% overvalued * The S&P Index according to my calculus remains about 10%-15% overvalued (current price: 3230; fair market value: about 2850) * But, with the concentrated outperformance o...
* Risk happens fast - as we now take the elevator down * At 4:45 am S&P futures were -90 and Nasdaq futures were -315 handles * Market structure - in which the majority of products and strategies are bullish and lie on "the same side of the boat" - ...
I thought it might be helpful to briefly summarize some of my more meaningful moves in the market over the last few weeks: * I eliminated Goldman Sachs around $240 (my year end 2020 target price) and reduced the size of my , and longs. Lower interes...
The pockets of strong trading action in individual stocks illustrates an appetite for speculative action.
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."